San Raffaele
| イタリア | トルコ | オーストリア | |
| 陽子線治療 | から $70,000 | から $70,000 | から $80,000 |
| 腹腔鏡下腎摘出術 | から $15,000 | から $12,830 | から $15,000 |
| 腎摘出術 | から $20,000 | から $10,000 | から $22,000 |
| 腎がん放射線治療 | から $11,200 | から $6,500 | から $6,841 |
| 大腸癌に対する放射線療法 | から $7,000 | から $7,000 | から $12,000 |
Bookimedは腎癌治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。腎癌治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。腎癌治療の旅路でお一人になることはありません。
Italy offers high-precision kidney cancer treatment at JCI-accredited and IRCCS-certified research hospitals. San Raffaele in Milan and Agostino Gemelli in Rome lead in surgical volume and innovation. These centers utilize da Vinci robotic systems and targeted immunotherapy to achieve high survival rates for renal tumors.
Bookimed Expert Insight: Data shows that San Raffaele performs over 52,000 operations annually. Choosing high-volume IRCCS centers in Milan or Rome ensures access to specific clinical trials. These research-focused institutions often provide newer immunotherapy drugs before they reach general hospitals.
Patient Consensus: Patients value the multidisciplinary approach where urologists and oncologists collaborate on one site. Many note that robotic surgery significantly shortened their hospital stay and reduced post-operative pain.
Italian centers offer advanced kidney cancer treatments including Da Vinci robotic surgery for partial nephrectomy. Patients access immunotherapy and targeted drugs like Pembrolizumab. Minimally invasive options like CyberKnife radiosurgery and cryotherapy are available inside JCI-accredited facilities. Specialized urology departments maintain kidney-sparing success rates up to 95% for localized tumors.
Bookimed Expert Insight: Italian urology excellence is driven by high-volume research hospitals like San Raffaele in Milan. This facility performs over 52,000 operations annually. Surgeons like Prof. Dr. Francesco Montorsi have completed over 8,000 urological surgeries. This vast experience level often leads to better preservation of healthy kidney tissue during complex tumor removals.
Italy is a safe and practical destination for kidney cancer surgery. It offers a 95% survival rate for nephrectomy procedures. Leading centers in Milan and Rome use three Da Vinci robotic systems. These facilities hold Joint Commission International and Newsweek rankings for oncology excellence.
Bookimed Expert Insight: Lombardy clinics like San Raffaele handle over 52,000 operations annually. This high volume correlates with advanced robotic proficiency. Data shows northern regions often provide quicker treatment pathways than southern areas. Patients seeking specific robotic expertise should focus on Milan-based centers for the most streamlined care.
Patient Consensus: Patients note that hiring a multilingual coordinator is vital as ward staff may have limited English. Those traveling from outside the EU emphasize planning for an extended stay of 14 days to prevent rushed discharges.
Verify Italian kidney cancer surgeons by checking the FNOMCeO national registry for a specialization in Urology or General Surgery. Prioritize surgeons at IRCCS-accredited research hospitals like San Raffaele in Milan. Ensure they hold international fellowships and have performed over 1,000 specialized procedures.
Bookimed Expert Insight: Italian surgical expertise is often concentrated in high-volume research hubs like Milan. Leading specialists such as Prof. Dr. Francesco Montorsi at San Raffaele have completed over 8,000 procedures. This volume is critical because data shows surgeons who operate on hundreds of patients annually maintain higher success rates with robotic and laparoscopic techniques than generalists.
Patient Consensus: Patients emphasize finding surgeons who are active members of the Italian Society of Urology. They note that personal communication about robotic surgery options is just as important as the surgeon's published research on PubMed.
Recovery after robotic kidney surgery in Italy typically lasts 4 to 8 weeks. Patients usually leave the hospital within 1 to 3 days. Most resume light desk work within 2 weeks. Full physical activity and heavy lifting are permitted after 4 to 6 weeks.
Bookimed Expert Insight: Italian research centers like San Raffaele specialize in ultra-minimally invasive protocols that eliminate bowel preparation. This allows patients to maintain a normal diet immediately after surgery. Data shows this approach often shortens the recovery period. Higher surgical volumes, such as the 8,000+ procedures performed by specialists like Dr. Francesco Montorsi, correlate with fewer complications and faster mobilization.
Patient Consensus: Patients note that light activity is possible early on. Many suggest stocking easy meals and using a walker for the first few days to aid movement.
Italian private hospitals offer online consultations for international patients before travel. Specialist networks and international patient departments provide video calls for second opinions. Private visits usually offer English-speaking doctors. Public institutions typically require in-person visits to initiate a formal treatment plan for oncology cases.
Bookimed Expert Insight: Italian medical centers like San Raffaele in Milan handle over 52,000 surgeries annually. High volumes at private IRCCS-accredited hospitals often mean faster access to robotic techniques. While some clinics require in-person visits, picking a hospital with a dedicated international department helps bypass local bureaucracy. This is vital when coordinating complex kidney cancer treatments like Da Vinci robotic surgery.
Patient Consensus: Patients note that public hospitals often prioritize locals and require physical presence. Seeking private specialists on digital platforms is faster for a quick initial opinion before flying.
Italian specialists hold a strong reputation for treating kidney cancer. They specialize in robotic surgery and complex oncology. Major centres like San Raffaele in Milan perform over 52,000 operations annually. Leading urologists are globally recognised for high-volume expertise and pioneering minimally invasive techniques.
Bookimed Expert Insight: Italian urology outcomes are driven by massive surgical volumes at research centres. Prof. Francesco Montorsi at San Raffaele is a Fellow of the Royal College of Surgeons of England. This UK recognition aligns with Australian standards. This makes Italian clinical reports highly accessible for an Australian GP.
Patient Consensus: Patients value the multidisciplinary structure in Italy. In this system, urologists and oncologists collaborate on complex cases. Patients should confirm that pathology and imaging can be transferred to Australia for follow-up care.
Italy hosts high-quality kidney cancer centres specialising in robotic and minimally invasive urology. Facilities like San Raffaele in Milan hold IRCCS status for research and surgery. These hospitals offer treatments including Da Vinci robotic nephrectomy and immunotherapy for complex renal cases.
Bookimed Expert Insight: While Italy is famous for its medical research, its real advantage lies in surgeon volume. Prof. Dr Francesco Montorsi at San Raffaele was the first non-American to receive the Hugh Hampton Young Award. His team has performed over 8,000 procedures. This level of experience often leads to better preservation of healthy kidney tissue during tumour removal.
Patient Consensus: Patients find it important to choose high-volume urology centres. They suggest looking at specific departments rather than just general hospital reputations. Many emphasise looking for multidisciplinary teams that coordinate surgery and pathology in one system.
Italian oncology centres provide kidney cancer treatments including robotic-assisted nephrectomies, immunotherapy, and targeted radiosurgery. Specialists at JCI-accredited facilities use Da Vinci robotic systems for kidney-sparing surgery. These options follow ESMO guidelines to treat both localised and metastatic renal cell carcinoma effectively.
Bookimed Expert Insight: Italian urology excellence is driven by high-volume research centres like San Raffaele. Specialists there, such as Prof. Dr Francesco Montorsi, have performed over 8,000 surgeries. This institutional experience leads to refined techniques in robotic-assisted kidney-sparing procedures. Patients benefit because surgeons at these major hubs manage complex cases that smaller clinics might refer elsewhere.
Italian urological centres commonly use robotic-assisted surgery for kidney cancer treatment. Specialists frequently use the da Vinci system for both partial and radical nephrectomies. Over 60% of partial nephrectomies in Italy use robotic platforms. This approach allows surgeons to remove tumours with high precision. It also helps spare healthy kidney tissue.
Bookimed Expert Insight: Italian urology centres demonstrate exceptional surgical density. San Raffaele in Milan performs over 52,000 operations annually across all departments. This high volume allows surgeons like Prof. Dr Francesco Montorsi to maintain deep expertise. Patients should look for high-volume IRCCS-accredited research hospitals to find experienced robotic teams.
Patient Consensus: Patients in Italy note it is important to confirm the surgical approach before booking. They suggest comparing the surgeon's case volume for your exact tumour type.
Active surveillance is a standard management strategy in Italy for early-stage kidney cancer. It is often used for small renal masses under 4 cm. Italian clinics follow guidelines set by the EAU (European Association of Urology). This approach is primarily for elderly or frail patients where surgery risks outweigh potential benefits.
Bookimed Expert Insight: Italy is a leader in robotic surgery. Centres like San Raffaele integrate clinical care with extensive urological research. Data shows that in these academic environments, patients often receive more nuanced surveillance protocols. Precise imaging, such as the PET-CT protocols used by specialists like Dr Vincenzo Arena, allows for accurate monitoring of tumour behaviour.
Patient Consensus: Patients in Italy note that surveillance is an active plan with strict imaging triggers. Those with masses under 4 cm highlight the importance of asking for clear intervention thresholds. This helps them manage the anxiety of regular scans.